The patient experience of relapsed refractory multiple myeloma and perspectives on emerging therapies

The patient experience of relapsed refractory multiple myeloma and perspectives on emerging therapies

Abstract Background Relapsed refractory multiple myeloma (RRMM) is a disease that is nonresponsive or progressive on therapy, and although patients can achieve remission, relapse is common. As more treatment options become available for multiple myeloma (MM), it is important to understand patients&#...

Full description

Bibliographic Details
Main Authors: Rebecca Crawford, Katharine S. Gries, Satish Valluri, John Fastenau, Ross Morrison, Tzu‐Min Yeh, Yunsi Olyslager, Jenna D. Goldberg, Jordan M. Schecter, Carolyn C. Jackson, William Deraedt, Lynda Doward
Format: Article
Language:English
Published: Wiley 2022-11-01
Series:Cancer Reports
Subjects:
immunotherapy
multiple myeloma
qualitative research
treatment choices
Online Access:https://doi.org/10.1002/cnr2.1603

Internet

https://doi.org/10.1002/cnr2.1603

Similar Items